Ads
related to: glaxosmithkline
Search results
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk - BusinessWorld...
BusinessWorld· 7 days agoGSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding...
23andMe Fiscal Q4 Revenues Drop 31 Percent as Research Services, Genetic Test Kit Sales Shrink
GenomeWeb News· 4 days agoThe firm attributed the decrease largely to lower research services revenue due to ending a collaboration with GlaxoSmithKline, as well as lower consumer services revenue ...
Infinant Health Appoints New Team Members to assist with Drug Development
FOX21 Colorado Springs· 6 days agoInfinant Health, a privately-held company focused on changing the trajectory of human health by supporting the development and restoration of the immune system via the gut microbiome, announces ...
AI Is Deciphering Your Corporate Trade Secrets
Forbes· 6 days agoIn the high-stakes world of corporate competition, trade secrets are the hidden gems that give companies their competitive edge. AI's ability to analyze, learn, and decipher complex patterns ...
Explainer-What to know about bird flu in dairy cows and the risk to humans By Reuters
Investing.com· 5 days agoCHICAGO (Reuters) -A second human case of bird flu was confirmed in a dairy worker in Michigan, U.S....
Tempus AI files to go public
Modern Healthcare· 6 days agoTempus declined to comment but plans for its stock to trade on the the Nasdaq Global Select Market under the ticker TEM. Tempus' database includes 7.7 million clinical records and is used by ...
Court backs drugmakers in limiting 340B distribution
Becker’s Hospital Review· 6 days agoThree judges for the U.S. Court of Appeals for the Washington, D.C. Circuit ruled May 21 in favor of drug manufacturers' ability to limit sales and distribution of discounted drugs in the government's ...
Potential blockbuster asthma drug met goals in trials, GSK says
Morningstar· 6 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both trials of depemokimab ...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Morningstar· 7 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both trials of depemokimab ...
Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...
The Business Journals· 5 days agoA biotechnology firm with operations in Durham is working on a major deal with with Eli Lilly and...